Article

timesofmalta.com on 2023-07-17 21:30

Drug found to slow Alzheimer’s in trial

Donanemab slowed the progression of symptoms by 35 per cent over 18 months

Related news

Drug found to slow Alzheimer’s by up to 60 percent in trial Al Jazeera
Japan , Amsterdam
Second Alzheimer’s drug in the pipeline promises to slow worsening but with safety concern Sun Sentinel
San Francisco , Amsterdam , Japan
New trial finds first-ever Alzheimer’s drug to slow cognitive decline newatlas.com
Second Alzheimer’s drug in pipeline can slow the disease by a few months but with safety risk LA Times
San Francisco , California , Amsterdam , Japan
New details emerge on drug that may slow Alzheimer’s disease Merced Sun-Star
United States , Japan , Cambridge , Mayo Clinic , San Diego
Alzheimer’s Drug Fails Trial wsj.com
Experimental Alzheimer’s drug slows cognitive decline in trial, firms say pressherald.com
San Francisco , Cambridge , Japan
New Alzheimer’s Drug Shows Big Promise in Early Trial The New York Times
Phase 1 , Phase 2 , Cambridge , Japan , Europe
U.S. approves Eisai and Biogen’s drug to slow Alzheimer’s disease The Japan Times
Utah , Americas , New York , Cambridge , United States
Experimental Alzheimer’s drug delivers promising Phase 2 trial results newatlas.com
San Francisco , Phase 2
Hopes rise again for a drug to slow Alzheimer’s disease The Findlay Courier
Chicago